Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > News > Study shows early changes in immune cells linked to COPD

Study shows early changes in immune cells linked to COPD

Date time 30 May, 2023
News Type News type Research News
Professor Phil Hansbro
A new study led by the Centenary Institute and the University of Bonn has revealed new insights into the early stages of chronic obstructive pulmonary disease (COPD), a debilitating respiratory condition characterised by inflammation in the lungs and severe breathing difficulties.

Published in the journal Cell Reports, the researchers found increased levels of five different types of immune cells, called neutrophils, in the blood of people with early-stage COPD. The cells are crucial in fighting off infection but they are also associated with disease when they become aberrant.

In this study, only one of these five cell types were linked to COPD disease features. The researchers also observed changes in the characteristics and functions of these neutrophils, which were linked to the decline in patient lung function. Similar neutrophil related changes were also observed in experimental models involving mice, commencing in the bone marrow and moving to the blood and then the lungs.

Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, joint senior author of the paper said the study suggests that there are changes happening in the immune cells of people with early-stage COPD, even before the disease progresses to severe stages. It shows that these specific types of neutrophils can be specifically targeted in new therapies in the blood before they reach the lungs. This would allow the other four neutrophil types to remain and fight off infections.

“These findings could potentially be used to develop new treatments and diagnostic tools for early detection and personalised management of COPD to enhance patients’ quality of life,” said Professor Hansbro.

Research paper: Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease. Lead author: Dr Theodore Kapellos, The Life and Medical Sciences Institute, University of Bonn.

[ENDS]

Themes

  • Inflammation

    Inflammation

Programs

  • Centenary UTS Centre for Inflammation

People

  • Professor Philip Hansbro

    Deputy Director, Centenary Institute. Director, Centenary UTS Centre for Inflammation

Research Fields

  • COPD – Chronic obstructive pulmonary disease

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Research to unlock the secrets of muscle loss in ageing

    The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap.
    News Type: Media release
    Date 28 Sep 2023
  • New treatment offers hope for advanced liver cancer

    Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide.
    News Type: Media release
    Date 26 Sep 2023
  • Meet Dr Bobby Boumelhem

    Dr Bobby Boumelhem, a dedicated researcher at the Centenary Institute, is on a mission to enhance the quality of life for individuals grappling with liver disease. Diseases such as hepatitis, liver cancer, non-alcoholic fatty liver disease and cirrhosis pose significant health challenges.
    News Type: Profiles
    Date 22 Sep 2023
  • Cancer drug for COVID-19

    Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients.
    News Type: Research News
    Date 19 Sep 2023

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram